Pulmonary pharmacology and therapeutics

Benralizumab in severe eosinophilic asthma in real life: confirmed effectiveness and contrasted effect on sputum eosinophilia versus exhaled nitric oxide fraction – PROMISE
Florence Schleich, Catherine Moermans, Laurence Seidel, Céline Kempeneers, Gilles Louis, Florence Rogister, Sophie Tombu, Laurence Pottier, Anne-Lise Poirrier, Stéphanie Ziant, Monique Henket, Carole Sanchez, Virginie Paulus, Françoise Guissard, Anne-Françoise Donneau, Renaud Louis

ERJ Open Research Nov 2023, 9 (6) 00383-2023; DOI: 10.1183/23120541.00383-2023
Long-term efficacy of dupilumab in severe asthma by baseline oral corticosteroid dose
Christian Domingo, Klaus F. Rabe, David Price, Guy Brusselle, Michael E. Wechsler, Changming Xia, Nami Pandit-Abid, Rebecca Gall, Paul J. Rowe, Yamo Deniz, Juby A. Jacob-Nara, Amr Radwan

ERJ Open Research Nov 2023, 9 (6) 00056-2023; DOI: 10.1183/23120541.00056-2023
Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis
Andrea Portacci, Raffaele Campisi, Enrico Buonamico, Santi Nolasco, Corrado Pelaia, Nunzio Crimi, Alida Benfante, Massimo Triggiani, Giuseppe Spadaro, Maria Filomena Caiaffa, Giulia Scioscia, Aikaterini Detoraki, Giuseppe Valenti, Francesco Papia, Alessandra Tomasello, Nicola Scichilone, Girolamo Pelaia, Claudia Crimi, Giovanna Elisiana Carpagnano

ERJ Open Research Sep 2023, 9 (5) 00419-2023; DOI: 10.1183/23120541.00419-2023
Effects of bepotastine, a nonsedating H1-antihistamine, for the treatment of persistent cough and allergic rhinitis: a randomised, double-blind, placebo-controlled trial
Ji-Hyang Lee, Ji-Yoon Oh, Hyouk-Soo Kwon, Tae-Bum Kim, You Sook Cho, Woo-Jung Song

ERJ Open Research Sep 2023, 9 (5) 00448-2023; DOI: 10.1183/23120541.00448-2023
A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2
Tom Wilkinson, Anthony De Soyza, Miles Carroll, James D. Chalmers, Michael G. Crooks, Gareth Griffiths, Manu Shankar-Hari, Ling-Pei Ho, Alex Horsley, Chris Kell, Beatriz Lara, Biswa Mishra, Rachel Moate, Clive Page, Hitesh Pandya, Jason Raw, Fred Reid, Dinesh Saralaya, Ian C. Scott, Salman Siddiqui, Andy Ustianowski, Natalie van Zuydam, Ashley Woodcock, Dave Singh

ERJ Open Research Sep 2023, 9 (5) 00249-2023; DOI: 10.1183/23120541.00249-2023
No effect of danazol treatment in patients with advanced idiopathic pulmonary fibrosis
Thijs W. Hoffman, Coline H.M. van Moorsel, Joanne J. van der Vis, Douwe H. Biesma, Jan C. Grutters

ERJ Open Research Sep 2023, 9 (5) 00131-2023; DOI: 10.1183/23120541.00131-2023
Oral corticosteroid use and sarcopenia-related traits in older people with chronic airway disease: a population-based study
Elizabeth Benz, Lies Lahousse, Johnmary T. Arinze, Sara Wijnant, Maria de Ridder, Fernando Rivadeneira, Guy Brusselle, Bruno H. Stricker

ERJ Open Research Sep 2023, 9 (5) 00492-2023; DOI: 10.1183/23120541.00492-2023
Tuberculosis medicines for children in Europe: an unmet medical need
Antonio Cherchi, Alexandra Vaz, Ana Coelho, Laura Fregonese, Steffen Thirstrup

ERJ Open Research Jul 2023, 9 (4) 00730-2022; DOI: 10.1183/23120541.00730-2022
Unexpected sirolimus-stimulated airway hyperreactivity in lymphangioleiomyomatosis
Wendy K. Steagall, Mario Stylianou, Gustavo Pacheco-Rodriguez, Zu Xi Yu, Joel Moss

ERJ Open Research Jul 2023, 9 (4) 00305-2023; DOI: 10.1183/23120541.00305-2023
Modified-release morphine or placebo for chronic breathlessness: the MABEL trial protocol
Kathryn Date, Bronwen Williams, Judith Cohen, Nazia Chaudhuri, Sabrina Bajwah, Mark Pearson, Irene Higginson, John Norrie, Catriona Keerie, Sharon Tuck, Peter Hall, David Currow, Marie Fallon, Miriam Johnson

ERJ Open Research Jul 2023, 9 (4) 00167-2023; DOI: 10.1183/23120541.00167-2023

Main menu

User menu

Search

Pulmonary pharmacology and therapeutics

Pages

Contact us